Tumor Sink Effect in


Journal

Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410

Informations de publication

Date de publication:
02 2022
Historique:
received: 04 01 2021
revised: 04 05 2021
pubmed: 30 5 2021
medline: 30 4 2022
entrez: 29 5 2021
Statut: ppublish

Résumé

We aimed to systematically determine the impact of tumor burden on

Identifiants

pubmed: 34049987
pii: jnumed.121.261906
doi: 10.2967/jnumed.121.261906
pmc: PMC8805781
doi:

Substances chimiques

Gallium Isotopes 0
Gallium Radioisotopes 0
gallium 68 PSMA-11 0
Edetic Acid 9G34HU7RV0

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

226-232

Subventions

Organisme : NCI NIH HHS
ID : P30 CA016042
Pays : United States
Organisme : NCI NIH HHS
ID : P50 CA211015
Pays : United States

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

© 2022 by the Society of Nuclear Medicine and Molecular Imaging.

Références

J Nucl Med. 2020 Jun;61(6):857-865
pubmed: 31732676
Clin Nucl Med. 2019 Jun;44(6):431-438
pubmed: 30985422
Eur J Nucl Med Mol Imaging. 2016 Oct;43(11):1962-70
pubmed: 27207281
Eur Urol. 2020 Aug;78(2):148-154
pubmed: 32532512
Eur Urol. 2021 Mar;79(3):343-350
pubmed: 33293081
J Nucl Med. 2020 Aug;61(8):1145-1152
pubmed: 31806776
Radiology. 2018 Jun;287(3):993-1002
pubmed: 29558296
Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):1014-1024
pubmed: 28283702
EJNMMI Res. 2020 Oct 30;10(1):132
pubmed: 33123814
Lancet Oncol. 2021 Aug;22(8):1115-1125
pubmed: 34246328
Eur J Nucl Med Mol Imaging. 2014 Feb;41(2):211-3
pubmed: 24221244
J Nucl Med. 2017 Mar;58(3):445-450
pubmed: 27660138
J Nucl Med. 2019 Sep;60(9):1277-1283
pubmed: 30850484
Lancet Oncol. 2018 Jun;19(6):825-833
pubmed: 29752180
Radiographics. 2003 Mar-Apr;23(2):341-58
pubmed: 12640151
Clin Genitourin Cancer. 2019 Feb;17(1):15-22
pubmed: 30425003
JAMA Oncol. 2019 Jun 1;5(6):856-863
pubmed: 30920593
BMC Cancer. 2020 Sep 14;20(1):884
pubmed: 32928177
EJNMMI Res. 2019 Dec 2;9(1):103
pubmed: 31792771
Lancet. 2020 Apr 11;395(10231):1208-1216
pubmed: 32209449
J Nucl Med. 2019 May;60(5):644-648
pubmed: 30442756
Oncotarget. 2017 Jul 6;8(33):55094-55103
pubmed: 28903405
J Nucl Med. 2019 Aug;60(8):1111-1117
pubmed: 30630941
Mol Imaging Biol. 2020 Feb;22(1):190-197
pubmed: 31140110
Eur J Nucl Med Mol Imaging. 2012 Jan;39(1):50-6
pubmed: 21932117
J Nucl Med. 2019 Apr;60(4):517-523
pubmed: 30291192

Auteurs

Andrei Gafita (A)

Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California; agafita@mednet.ucla.edu.
Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University Munich, Munich, Germany.

Hui Wang (H)

Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University Munich, Munich, Germany.

Andrew Robertson (A)

Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University Munich, Munich, Germany.

Wesley R Armstrong (WR)

Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California.

Raphael Zaum (R)

Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University Munich, Munich, Germany.

Manuel Weber (M)

Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium-University Hospital Essen, Essen, Germany.

Farid Yagubbayli (F)

Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University Munich, Munich, Germany.

Clemens Kratochwil (C)

Department of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany.

Tristan R Grogan (TR)

Department of Medicine Statistics Core, David Geffen School of Medicine, UCLA, Los Angeles, California.

Kathleen Nguyen (K)

Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California.

Fernando Navarro (F)

Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University Munich, Munich, Germany.
Department of Informatics, Technical University Munich, Munich, Germany.

Rouzbeh Esfandiari (R)

Excel Diagnostics and Nuclear Oncology Center, Houston, Texas.

Isabel Rauscher (I)

Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University Munich, Munich, Germany.

Bjoern Menze (B)

Department of Informatics, Technical University Munich, Munich, Germany.
Department of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland; and.

David Elashoff (D)

Department of Medicine Statistics Core, David Geffen School of Medicine, UCLA, Los Angeles, California.

Ebrahim S Delpassand (ES)

Excel Diagnostics and Nuclear Oncology Center, Houston, Texas.

Ken Herrmann (K)

Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium-University Hospital Essen, Essen, Germany.

Johannes Czernin (J)

Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California.

Michael S Hofman (MS)

Prostate Cancer Theranostics and Imaging Centre of Excellence, Molecular Imaging and Therapeutic Nuclear Medicine, Peter MacCallum Cancer Centre, and Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.

Jeremie Calais (J)

Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California.

Wolfgang P Fendler (WP)

Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium-University Hospital Essen, Essen, Germany.

Matthias Eiber (M)

Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University Munich, Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH